CEBP Meeting Calendar Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Epidemiology Biomarkers & Prevention 17, 810, April 1, 2008. doi: 10.1158/1055-9965.EPI-07-2865
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boulet, G. A.V.
Right arrow Articles by Bogers, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boulet, G. A.V.
Right arrow Articles by Bogers, J.
Related Collections
Right arrow Review
Right arrow Epidemiology and Prevention
Right arrow Epidemiology and Prevention: Genetics and Biomarkers

Minireview

Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker

Gaëlle A.V. Boulet1, Caroline A.J. Horvath1, Sarah Berghmans2 and Johannes Bogers1,2

1 Applied Molecular Biology Research Group (AMBIOR), Laboratory for Cell Biology and Histology, University of Antwerp, Antwerp, Belgium; and 2 Laboratory for Clinical Pathology (Labo Lokeren, campus RIATOL), Antwerp, Belgium

Requests for reprints: Gaëlle Boulet, AMBIOR, Laboratory of Cell Biology and Histology, University of Antwerp Groenenborgerlaan 171, 2020 Antwerp, Belgium. Phone: 32-3-265-33-25; Fax: 32-3-265-33-26; E-mail: gaelle.boulet{at}ua.ac.be

Cervical cytology screening has reduced cervical cancer morbidity and mortality but shows important shortcomings in terms of sensitivity and specificity. Infection with distinct types of human papillomavirus (HPV) is the primary etiologic factor in cervical carcinogenesis. This causal relationship has been exploited for the development of molecular technologies for viral detection to overcome limitations linked to cytologic cervical screening. HPV testing has been suggested for primary screening, triage of equivocal Pap smears or low-grade lesions and follow-up after treatment for cervical intraepithelial neoplasia. Determination of HPV genotype, viral load, integration status and RNA expression could further improve the effectiveness of HPV-based screening and triage strategies. The prospect of prophylactic HPV vaccination stresses the importance of modification of the current cytology-based screening approach. (Cancer Epidemiol Biomarkers Prev 2008;17(4):810–7)




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
P. Cattani, A. Siddu, S. D'Onghia, S. Marchetti, R. Santangelo, V. G. Vellone, G. F. Zannoni, and G. Fadda
RNA (E6 and E7) Assays versus DNA (E6 and E7) Assays for Risk Evaluation for Women Infected with Human Papillomavirus
J. Clin. Microbiol., July 1, 2009; 47(7): 2136 - 2141.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.